Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronique Moerman

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
European Heart Journal. Case Reports|April 26, 2019
Statin-induced myopathy: a case reportEmmanuel De Cock, Heidi Hannon, Veronique Moerman, et al.
Acta Clinica Belgica|February 28, 2026
Clinical characteristics and lipid management of patients with familial hypercholesterolemia: results from a 7 years single-centre experienceAmber Vanhulle, Dilara Yurdaer, Lynn van Calster, et al.
The American Journal of Cardiology|March 1, 2014
Impact of the preoperative risk and the type of surgery on exercise capacity and training after valvular surgerySofie Pardaens, Veronique Moerman, Anne-Marie Willems, et al.
Pharmaceuticals (Basel, Switzerland)|April 28, 2023
Extensive CArdioVAscular Characterization and Follow-Up of Patients Receiving Immune Checkpoint Inhibitors: A Prospective Multicenter StudyDanielle Delombaerde, Johan De Sutter, Lieselot Croes, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2024
Close Cardiovascular Monitoring during the Early Stages of Treatment for Patients Receiving Immune Checkpoint InhibitorsDanielle Delombaerde, Christof Vulsteke, Nico Van de Veire, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
European Heart Journal. Case Reports|April 26, 2019
Statin-induced myopathy: a case reportEmmanuel De Cock, Heidi Hannon, Veronique Moerman, et al.
Acta Clinica Belgica|February 28, 2026
Clinical characteristics and lipid management of patients with familial hypercholesterolemia: results from a 7 years single-centre experienceAmber Vanhulle, Dilara Yurdaer, Lynn van Calster, et al.
The American Journal of Cardiology|March 1, 2014
Impact of the preoperative risk and the type of surgery on exercise capacity and training after valvular surgerySofie Pardaens, Veronique Moerman, Anne-Marie Willems, et al.
Pharmaceuticals (Basel, Switzerland)|April 28, 2023
Extensive CArdioVAscular Characterization and Follow-Up of Patients Receiving Immune Checkpoint Inhibitors: A Prospective Multicenter StudyDanielle Delombaerde, Johan De Sutter, Lieselot Croes, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2024
Close Cardiovascular Monitoring during the Early Stages of Treatment for Patients Receiving Immune Checkpoint InhibitorsDanielle Delombaerde, Christof Vulsteke, Nico Van de Veire, et al.
Pageof 1